Healthcare Providers and Services
Company Overview of The Vanderbilt-Ingram Cancer Center
The Vanderbilt-Ingram Cancer Center engages in cancer research, treatment, support, prevention, education, and outreach. Its cancer clinics and programs include cancer information programs, cancer supportive care clinics, and patient resource centers, as well as medical, radiation, and surgical oncology centers; and bone and soft tissue, brain tumor, endocrine surgery, gastroenterology, general clinical research, hematology, otolaryngology, outpatient transplant, patient and family support, plastic surgery, thoracic surgery, and urology clinics and programs. The company also owns specific cancer units, including gastrointestinal, gynecologic, head and neck, orthopaedic, rehabilitation thorac...
691 Preston Building
Nashville, TN 37232
Founded in 1993
Key Executives for The Vanderbilt-Ingram Cancer Center
Compensation as of Fiscal Year 2016.
The Vanderbilt-Ingram Cancer Center Key Developments
Vanderbilt-Ingram Cancer Center Appoints Jeremy Warner as Medical Director of the Vanderbilt Cancer Registry
Feb 11 16
Jeremy Warner, M.D., M.S., assistant professor of Medicine and Biomedical Informatics, has been named medical director of the Vanderbilt Cancer Registry at Vanderbilt-Ingram Cancer Center (VICC). In this newly created position, Warner will work closely with Dauphne McGavic, MSN, R.N., CTR, who recently was appointed program manager of the Registry. Warner will assist the staff in identifying and developing new informatics methods to improve the accuracy and timeliness of the data collection process, including strategies to connect with current and future electronic medical record systems. He will be involved in assessing diagnoses that are difficult to categorize as a specific form of cancer and will serve as a liaison between clinicians and the registry staff.
The Vanderbilt-Ingram Cancer Center Debuts New Radiation Oncology Device
Jan 27 16
The Vanderbilt-Ingram Cancer Center has unveiled a new TrueBeam linear accelerator in the Department of Radiation Oncology on the main campus to provide enhanced radiation therapy for patients. Linear accelerators work by focusing therapeutic doses of radiation to a specific part of the body through a series of lead panels, or 'leaves,' that move in and out at pre-set points and angles to help shape the radiation beam. The TrueBeam system features an improved leaf design that results in less incidental radiation exposure to uninvolved organs and tissues. Additionally, the device has an enhanced on-board imaging system, which can track patients' movements during treatment and allows physicians to see the patients' tumors and normal organs much more clearly.
Incyte Corporation and Vanderbilt-Ingram Cancer Center Establish Multi-Year Oncology Research Alliance
Jul 7 15
Incyte Corporation announced that it has entered into a multi-year research support and collaboration agreement with Vanderbilt-Ingram Cancer Center (VICC) at Vanderbilt University Medical Center (VUMC), whereby Incyte will provide funding for certain aspects of Vanderbilt’s cancer research activities. This alliance is designed to develop an improved understanding of basic cancer biology and the mechanisms of action of certain Incyte-proprietary compounds, as well as identify and develop novel approaches to patient selection which may enable new therapeutic opportunities in oncology.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|